H2020Individual fellowship2020–2023

OMG · OIT3: A novel Magnesiotropic Gene in Kidney

Horizon 2020 — Marie Skłodowska-Curie Actions

Duration
2020-05-01 → 2023-10-16
EU contribution
€253,052
Participants
3
Scheme
MSCA-IF

Lines connect the coordinator with its partners.

Results in brief

OIT3: A novel Magnesiotropic Gene in Kidney

Magnesium. is the second most abundant intracellular cation after potassium and it plays an essential role in the human body. Magnesium. serves as a cofactor in more than 600 enzymatic reactions that are crucial for life. Approximately 30-50% of dietary magnesium is absorbed by the intestines, subsequently reaching the blood stream to act on different organs or get stored in bones. Finally, the kidney will determine the final excretion in a tightly regulated process. Alterations in magnesium balance are associated with several diseases. Hypomagnesemia (serum Mg2+ levels below 0.70 mmol/L) or magnesium deficiency is the most common form of magnesium disturbance and it can be due to impaired intestinal magnesium absorption or renal loss of magnesium. Remarkably, hypomagnesemia is associated with highly prevalent metabolic disorders (e.g. diabetes, metabolic syndrome). In the past, some genetic causes of hypomagnesemia and renal magnesium wasting (increased loss of magnesium through the urine) have been identified in humans, encompassing mutations in magnesiotropic genes. This enables us to decipher the mechanisms involved in magnesium transport and kidney (patho)physiology. To date, many cases of magnesium disturbances (e.g. seen in metabolic disease) cannot be explained with the current knowledge, meaning that there is a clinical need to further elucidate the mechanisms underlying hypomagnesemia to find an effective treatment. Recently, we have identified several genes linked to kidney function in mice. Interestingly, one of the genes identified (Oit3) was associated with variations in urinary magnesium excretion. However, the mechanisms by which Oit3 regulates magnesium balance and its physiological relevance are unknown. Thanks to preliminary results we hypothesized that OIt3 regulates magnesium handling by modulating key magnesium transporters or proteins associated to magnesium balance in the kidney. The aim of the present project is to decipher the function of Oit3 on magnesium balance and unravel the molecular mechanisms by which it regulates magnesium handling. The overall objectives of this project are to understand the physiological role of our gene of interest in magnesium balance in a mice model and unravel the molecular mechanisms using a cell model by doing a functional characterization of the impact of this gene on magnesium transport and the interactions with ion channels and transporters.

Data: CORDIS, © European Union

Project objective

Mg2+ is the second most abundant intracellular cation after potassium and it plays an essential role in the human body. The kidney is the key organ regulating Mg2+ homeostasis through complex processes of excretion and reabsorption. This takes place in the nephrons, the functional units of the kidney, via paracellular mechanisms and ion transporters. Alterations in Mg2+ homeostasis are associated with several diseases and vice versa. Hypomagnesemia (serum Mg2+ <0.70 mmol/L) is the most common form of Mg2+ disturbance which can be due to impaired intestinal Mg2+ absorption or renal Mg2+ wasting. Remarkably, hypomagnesemia is associated with highly prevalent metabolic disorders including diabetes and metabolic syndrome. In the past, many genetic causes of hypomagnesemia and renal Mg2+ wasting have been identified in humans, encompassing mutations in magnesiotropic genes. This has been crucial to decipher part of the mechanisms involved in Mg2+ transport and renal (patho)physiology. However, many cases of Mg2+ disturbances cannot be explained with the current knowledge, meaning that there is a clinical need to further elucidate the mechanisms underlying hypomagnesemia to find an effective treatment. Recently, we have discovered OIT3, a new gene involved in Mg2+ handling. However, the mechanisms of action and its physiological role need to be deciphered. The aim of the present project is to unravel the physiological role and mechanisms of action of OIT3 in relation to Mg2+ handling as well as find clinical indications from human kidney disease where OIT3 can play a role. Applying a wide range of techniques including electrolyte analysis, advanced microscopy, RNAseq and bioinformatics, I will provide mechanistic insights and a holistic view into the role of OIT3 in renal Mg2+ homeostasis. This approach will contribute to the discovery of potential therapeutic targets and biomarkers of electrolyte-related kidney disease.

Original text from CORDIS.

Participants

  • STICHTING RADBOUD UNIVERSITAIR MEDISCH CENTRUM · NijmegenCoordinatorNetherlands
  • STICHTING RADBOUD UNIVERSITEIT · NijmegenNetherlands
  • THE JACKSON LABORATORY NON PROFIT CORPORATION · Bar HarborUnited States

Links

Data: CORDIS, © European Union